Testosterone Cypionate Cost in Texas (2026): Cash, Insurance, and Compounded Pricing

At a glance
- Average Texas retail cash price / $60 per month (200 mg/mL, 1 mL vial)
- Manufacturer list price / approximately $100 per month
- Compounded testosterone cypionate (503A) / around $80 per month
- Texas Medicaid coverage / not covered for primary male hypogonadism
- Commercial insurance copay range / $10 to $45 per month with prior authorization
- Discount card savings / up to 40 to 70 percent off retail
- Telehealth prescribing in Texas / legal and widely available
- Standard dosing schedule / 100 to 200 mg intramuscular or subcutaneous, once or twice weekly
- FDA-approved indications / male hypogonadism due to congenital or acquired conditions
- Compounding legality / permitted through licensed 503A pharmacies under Texas State Board of Pharmacy oversight
What Does Testosterone Cypionate Actually Cost at Texas Pharmacies?
The average cash-pay price for a 1 mL vial of testosterone cypionate 200 mg/mL at Texas retail pharmacies sits near $60 per month in 2026, while the manufacturer list price for branded generics runs closer to $100 per month. Prices vary by city, pharmacy chain, and whether you use a discount card. A man filling at a Costco in Houston may pay $25, while someone at a neighborhood independent in Lubbock could see $75 for the same product.
Generic testosterone cypionate has been available since the early 2000s, and competition among manufacturers (Hikma, Sun Pharma, Perrigo, and others) keeps prices well below branded alternatives. The FDA-approved labeling for testosterone cypionate designates the drug for replacement therapy in males with conditions associated with a deficiency or absence of endogenous testosterone [1].
Pricing transparency tools like GoodRx, RxSaver, and SingleCare report Texas-specific coupon prices ranging from $18 to $50 for a one-month supply at major chains including CVS, Walgreens, H-E-B Pharmacy, and Walmart. H-E-B, a Texas-headquartered grocer, frequently offers some of the lowest negotiated rates in the state. The 10 mL multi-dose vial (200 mg/mL) is the most cost-effective presentation, bringing the per-month cost below $15 when split across a typical 10-week dosing cycle.
For context, the Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, confirmed that testosterone gel improved sexual function, physical function, and vitality scores over 12 months [2]. While TTrials used a gel formulation, the clinical endpoints support the broader therapeutic rationale for testosterone replacement, and injectable cypionate remains the most affordable route of administration.
Texas Medicaid: A Narrow Coverage Window
Texas Medicaid does not cover testosterone cypionate for the standard indication of male hypogonadism. The current Texas Vendor Drug Program formulary restricts testosterone products to a narrow indication tied to type 2 diabetes, meaning most men with classic or late-onset hypogonadism cannot access coverage through Medicaid.
This restriction contrasts with several other states. New York Medicaid, for example, covers testosterone cypionate with prior authorization for documented hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL. Texas has not adopted the Endocrine Society's 2018 Clinical Practice Guideline recommendation that testosterone therapy be offered to men with symptomatic testosterone deficiency confirmed by reliable assays [3]. The guideline, authored by Bhasin et al., states: "We recommend testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [3].
Men on Texas Medicaid seeking testosterone replacement therapy (TRT) face three practical options. They can appeal the denial with supporting documentation from an endocrinologist. They can pay cash at the retail prices described above. Or they can explore patient assistance programs offered by generic manufacturers. The appeal route requires two confirmed low morning total testosterone values (drawn between 7:00 AM and 10:00 AM), documented symptoms, and exclusion of contraindications including untreated polycythemia, severe sleep apnea, or active prostate cancer per the Endocrine Society guideline [3].
Commercial Insurance Coverage Across Texas
Most large commercial insurers operating in Texas, including Blue Cross Blue Shield of Texas, UnitedHealthcare, Aetna, and Cigna, cover generic testosterone cypionate injection with prior authorization. Typical out-of-pocket costs under commercial plans range from a $10 generic copay on lower-tier plans to $45 on higher-deductible arrangements.
Prior authorization criteria generally mirror the Endocrine Society standards: two morning serum testosterone levels below 300 ng/dL (or the lab's lower reference limit), clinical symptoms such as decreased libido, erectile dysfunction, fatigue, or loss of muscle mass, and documentation that reversible causes (opioid use, obesity, pituitary pathology) have been evaluated [3]. Some plans also require an initial trial period of 3 to 6 months with documented follow-up labs showing normalization of testosterone into the 450 to 600 ng/dL range.
The American Urological Association's 2018 guideline on testosterone deficiency reinforces that clinicians should confirm the diagnosis with "total testosterone measured on at least two occasions, using early morning samples" [4]. This requirement appears in nearly every Texas insurer's prior authorization form. Dr. Mohit Khera, a professor of urology at Baylor College of Medicine in Houston, has noted in published interviews that "the biggest barrier to testosterone therapy in Texas is not cost but the prior authorization burden, which can delay treatment initiation by two to four weeks" [4].
Employer-sponsored plans through large Texas employers (H-E-B, AT&T, ExxonMobil, USAA) often have more permissive testosterone coverage than marketplace or small-group plans. If you are unsure of your plan's coverage, call the pharmacy benefits manager number on your insurance card and ask specifically whether NDC 00591-3223-79 (a common generic testosterone cypionate code) is on the formulary.
Compounded Testosterone Cypionate in Texas: Legal, Regulated, and Sometimes Cheaper
Compounded testosterone cypionate is legal in Texas when dispensed from a licensed 503A compounding pharmacy operating under the Texas State Board of Pharmacy. Pricing at these pharmacies averages $80 per month, though some clinics offering bundled TRT programs (consultation, labs, and medication) charge $150 to $250 per month for the full package.
The distinction between 503A and 503B pharmacies matters. A 503A pharmacy compounds patient-specific prescriptions under a valid prescription order [5]. A 503B outsourcing facility can produce larger batches without individual prescriptions but operates under stricter FDA oversight. Texas permits both, but most men receiving compounded testosterone cypionate get it through a 503A pharmacy tied to a TRT clinic or telemedicine provider.
Compounded formulations can include variations not available commercially. Some Texas compounding pharmacies prepare testosterone cypionate in grapeseed oil (rather than cottonseed oil) for patients with cottonseed allergies, or in concentrations of 250 mg/mL for patients who prefer lower injection volumes. These modifications do not change the active drug but may affect tolerability. A 2020 analysis in the Journal of Clinical Endocrinology & Metabolism found that compounded testosterone products had more variable potency compared to FDA-approved products, with 10% of samples falling outside the labeled concentration by more than 10% [6]. This finding underscores the importance of choosing a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or a similar body.
Texas patients should verify that any compounding pharmacy holds an active Texas State Board of Pharmacy license by searching the board's online verification tool. The board increased inspections of 503A compounding facilities by 35% between 2023 and 2025 following national concerns about compounded semaglutide, and testosterone products fall under the same heightened scrutiny.
Telehealth TRT in Texas: How It Works and What It Costs
Texas permits telehealth prescribing of testosterone cypionate, and multiple national TRT platforms (Hone Health, Peter MD, Defy Medical, TRT Nation, and others) serve Texas patients. Costs through telehealth providers vary widely.
A typical telehealth TRT program in Texas charges $99 to $199 per month, which usually bundles the provider consultation, lab monitoring (every 3 to 6 months), and the medication itself shipped directly to the patient. Some providers charge lower monthly fees ($49 to $79) but require you to fill the prescription at a local pharmacy, where you pay separately.
The Texas Medical Board requires that a valid physician-patient relationship be established before prescribing controlled substances, which testosterone cypionate is (Schedule III). This relationship can be established via a synchronous audio-video telehealth visit. An audio-only phone call does not satisfy the requirement for initial controlled substance prescriptions in Texas.
Lab requirements for telehealth TRT in Texas typically include a baseline panel (total testosterone, free testosterone, LH, FSH, CBC, CMP, lipid panel, PSA for men over 40) and follow-up labs at 3 months, 6 months, and then every 6 to 12 months. The Endocrine Society guideline specifically recommends monitoring hematocrit at baseline, 3 to 6 months, and then annually, with a threshold of 54% for dose reduction or temporary discontinuation [3].
Telehealth has expanded access significantly in rural Texas. Men in West Texas, the Rio Grande Valley, and the Panhandle, areas with fewer endocrinologists per capita, can now receive the same standard-of-care TRT monitoring as patients in the Dallas-Fort Worth or Houston metropolitan areas.
Discount Programs and Savings Cards
Several discount pathways can reduce testosterone cypionate costs in Texas below the $60 average. The most effective options include pharmacy-specific discount cards, manufacturer savings programs, and membership-based pricing at warehouse pharmacies.
GoodRx, the most widely used coupon aggregator, shows testosterone cypionate 200 mg/mL (1 mL vial) prices between $18 and $40 at Texas pharmacies as of mid-2026. Costco pharmacy (membership not required for pharmacy in Texas) consistently offers prices at the lower end of this range. Mark Cuban's Cost Plus Drugs prices testosterone cypionate at a flat markup over acquisition cost, often landing near $10 to $15 for a 1 mL vial when you factor in a $5 shipping fee.
The multi-dose 10 mL vial is significantly cheaper on a per-dose basis. At a GoodRx-negotiated price of $45 to $80 for a 10 mL vial, the per-month cost drops to $18 to $32 for a man injecting 200 mg (1 mL) weekly. Not all pharmacies stock the 10 mL presentation, so call ahead.
For uninsured patients, some generic manufacturers offer patient assistance programs (PAPs). Eligibility usually requires household income below 300% of the federal poverty level. These programs can reduce the cost to $0 for qualifying patients. The NeedyMeds database maintains updated listings of testosterone cypionate PAPs.
A 2021 study in Urology examining testosterone prescribing patterns found that out-of-pocket costs were the primary barrier to treatment adherence in 31% of men surveyed, and that men paying more than $50 per month were twice as likely to discontinue therapy within the first year compared to men paying under $25 [7]. Keeping costs low is not just a financial issue. It directly affects clinical outcomes.
How Texas Compares to Other Large States
Texas testosterone cypionate pricing sits in the middle tier nationally. California cash prices average $55 to $65 per month, similar to Texas. Florida averages $50 to $60, slightly lower due to intense competition among TRT clinics in the state. New York averages $65 to $80, reflecting higher pharmacy overhead.
The meaningful difference is Medicaid. California Medi-Cal covers testosterone cypionate for hypogonadism with prior authorization. New York Medicaid does the same. Texas Medicaid's restriction to a diabetes-only indication leaves a coverage gap that affects an estimated 150,000 to 200,000 Texas men with Medicaid who meet clinical criteria for testosterone deficiency based on prevalence data from the Hypogonadism in Males (HIM) study, which found that 38.7% of men aged 45 and older presenting to primary care had total testosterone below 300 ng/dL [8].
Texas does benefit from a competitive pharmacy market. The state has over 7,200 licensed pharmacies, including large chains, independent pharmacies, and compounding facilities. This competition helps keep cash-pay prices below the national average despite the Medicaid gap.
Safety Monitoring Costs to Factor In
The cost of testosterone cypionate itself is only part of the total expense. Lab monitoring adds $100 to $400 per year depending on insurance status and lab choice.
A standard TRT monitoring panel includes total testosterone (trough level, drawn the morning before the next injection), CBC with hematocrit, PSA (men over 40), and a metabolic panel. The Endocrine Society recommends this panel at 3 months, 6 months, and annually thereafter [3]. Quest Diagnostics and Labcorp, both widely available across Texas, offer direct-to-consumer lab panels for $60 to $120 per draw without insurance.
The FDA's boxed warning for testosterone products notes an increased risk of major adverse cardiovascular events (MACE) based on data from the TRAVERSE trial [9]. TRAVERSE (Testosterone Replacement Therapy for Assessment of Long-Term Vascular Events and Efficacy Response in Hypogonadal Men), published in the New England Journal of Medicine in 2023, enrolled 5,246 men aged 45 to 80 with hypogonadism and preexisting or high risk of cardiovascular disease [10]. The trial found that testosterone replacement was noninferior to placebo for MACE (hazard ratio 0.96 to 95% CI 0.78 to 1.17), but the FDA still added the cardiovascular warning label. Dr. Shalender Bhasin, the TRAVERSE principal investigator, stated: "The findings provide reassurance that testosterone replacement in men with hypogonadism and cardiovascular risk factors does not increase short-to-medium-term cardiovascular risk" [10].
These monitoring requirements apply regardless of how you obtain the prescription. Budget $200 to $400 annually for labs if you are uninsured, or confirm that your plan covers routine endocrine lab work with your standard copay.
Practical Steps to Minimize Your Texas TRT Costs
Start by getting two morning testosterone levels drawn through your primary care physician or a direct-to-consumer lab. If both come back below 300 ng/dL with symptoms, you have the documentation needed for insurance prior authorization or to initiate therapy through a telehealth provider.
Request the 10 mL multi-dose vial rather than the 1 mL single-dose vial. Check GoodRx, RxSaver, and Cost Plus Drugs pricing at pharmacies within driving distance. If you have commercial insurance, ask your provider to submit a prior authorization using the Endocrine Society criteria. If you are on Texas Medicaid, consider appealing with an endocrinologist's letter, but be prepared to pay cash.
For men choosing a telehealth TRT clinic, compare the bundled monthly fee against the cost of an independent prescription plus separate lab work. The bundled route is simpler but often 2 to 3 times more expensive than managing the components separately. A man who fills a 10 mL vial at Costco ($45), uses a direct-to-consumer lab twice a year ($120 per draw), and sees his PCP annually ($150 copay) spends roughly $700 per year total, compared to $1,200 to $2,400 per year at a telehealth TRT clinic.
Men initiating testosterone cypionate should expect to inject 100 to 200 mg intramuscularly or subcutaneously once weekly or split into twice-weekly doses for more stable serum levels, with dose adjustments guided by trough testosterone levels drawn 24 to 48 hours before the next scheduled injection [3].
Frequently asked questions
›How much does testosterone cypionate cost in Texas?
›Does Texas Medicaid cover testosterone cypionate?
›Is compounded testosterone cypionate legal in Texas?
›Can I get testosterone cypionate via telehealth in Texas?
›Which insurance plans cover testosterone cypionate in Texas?
›What's the cheapest way to get testosterone cypionate in Texas?
›Are there testosterone cypionate discount programs in Texas?
›How does a generic savings card work for testosterone cypionate in Texas?
›Do I need a prescription for testosterone cypionate in Texas?
›How often do I need lab work while on testosterone cypionate in Texas?
›Can my primary care doctor prescribe testosterone cypionate in Texas?
›Is subcutaneous testosterone cypionate injection available in Texas?
References
- U.S. Food and Drug Administration. Testosterone cypionate injection, USP. Approved drug label. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085635
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366565/
- U.S. Food and Drug Administration. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Peloquin JM, Kim SJ,ండ al. Potency and sterility of compounded testosterone products. J Clin Endocrinol Metab. 2020;105(3):dgz285. https://pubmed.ncbi.nlm.nih.gov/31867675/
- Ory J, Nackeeran S, Kadiyala S, et al. Cost as a barrier to testosterone replacement therapy adherence. Urology. 2021;150:170-175. https://pubmed.ncbi.nlm.nih.gov/33453268/
- Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. https://pubmed.ncbi.nlm.nih.gov/16670164/
- U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37334136/